Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cango ADR | CANG | Nov 15, 2024 | 3.76 | +1.08 |
Canna-Global Acquisition Unit | CNGLU | Nov 15, 2024 | 10.51 | 0.00 |
Cannae | CNNE | Nov 15, 2024 | 20.29 | -0.69 |
Canoo A | GOEV | Nov 15, 2024 | 0.50 | -6.14 |
Canopy Growth | CGC | Nov 15, 2024 | 3.73 | -0.27 |
Cantaloupe | CTLP | Nov 15, 2024 | 8.72 | -2.35 |
Canterbury Park | CPHC | Nov 15, 2024 | 19.50 | -4.60 |
Cantor Equity Partners | CEP | Nov 15, 2024 | 10.25 | 0.00 |
Capital Bancorp | CBNK | Nov 15, 2024 | 27.85 | +0.18 |
Capital City Bank Group | CCBG | Nov 15, 2024 | 38.34 | -0.62 |
Capital Clean Energy Carriers | CCEC | Nov 15, 2024 | 18.79 | 0.00 |
Capital One Financial | COF | Nov 15, 2024 | 185.14 | +1.17 |
Capital One Financial I Pref | COF-I | Nov 15, 2024 | 20.44 | -0.49 |
Capital One Financial J Pref | COF-J | Nov 15, 2024 | 19.37 | -0.41 |
Capital One Financial K Pref | COF-K | Nov 15, 2024 | 19.33 | -0.87 |
Capital One Financial L Pref | COF-L | Nov 15, 2024 | 18.55 | -0.43 |
Capital One Financial N Pref | COF-N | Nov 15, 2024 | 17.65 | -0.45 |
Capital Southwest | CSWC | Nov 15, 2024 | 22.88 | -0.57 |
Capitol Federal Financial | CFFN | Nov 15, 2024 | 6.84 | +0.15 |
Capri Holdings | CPRI | Nov 15, 2024 | 21.00 | +2.34 |
Capricor Therapeutics | CAPR | Nov 15, 2024 | 18.61 | +0.65 |
Captivision | CAPT | Nov 15, 2024 | 0.88 | -10.51 |
Cara Therapeutics | CARA | Nov 15, 2024 | 0.31 | -5.04 |
Caravelle International Group | CACO | Nov 15, 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | Nov 15, 2024 | 2.99 | -8.27 |
Cardiff Oncology | CRDF | Nov 15, 2024 | 2.58 | -9.15 |
Cardinal Health | CAH | Nov 15, 2024 | 118.78 | -2.07 |
Cardio Diagnostics | CDIO | Nov 15, 2024 | 0.26 | -3.85 |
Cardiol Therapeutics | CRDL | Nov 15, 2024 | 1.82 | -2.15 |
Cardlytics | CDLX | Nov 15, 2024 | 3.38 | -5.98 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.